A Phase I, Open, Randomized, Single-centre, 3-way Crossover Drug-drug Interaction Study of Esomeprazole Capsule 40 mg and Low-dose Acetylsalicylic Acid Tablet 325 mg after 5 days Repeated Oral Administration in Healthy Male and Female Subjects
Study identifier:D961FC00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase I, Open, Randomized, Single-centre, 3-way Crossover Drug-drug Interaction Study of Esomeprazole Capsule 40 mg and Low-dose Acetylsalicylic Acid Tablet 325 mg after 5 days Repeated Oral Administration in Healthy Male and Female Subjects
Medical condition
peptic ulcer
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 May 2007
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
